{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:06:19Z","timestamp":1792800379677,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key R&D and Promotion Project of Henan Science and Technology Department under Grant","award":["201801591"],"award-info":[{"award-number":["201801591"]}],"id":[{"id":"https:\/\/ror.org\/058p20n09","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key Scientific Research Project of Universities of Henan Education Department under Grant","award":["19A320066"],"award-info":[{"award-number":["19A320066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To evaluate the additive effects of orthokeratology (OK) lenses and 0.01% atropine on slowing axial elongation in myopic children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A prospective, randomized, double-blinded, placebo-controlled trial was conducted over a 12-month period. Sixty children aged 8 to 12 years with spherical equivalent refraction from \u2212\u20091.00 to -4.00 D who had been wearing OK lenses successfully for 2 months (as baseline) were randomly assigned in a 1:1 ratio to combination group (combination of OK lens and 0.01% atropine eye drops) and control group (combination of OK lens and placebo). The primary outcome was change in axial length, along with secondary outcomes including change in pupil diameter (PD) and accommodative amplitude (AMP) at 12 months (measured at 4-month intervals).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>After 12 months, the overall axial elongation was 0.10\u2009\u00b1\u20090.14\u00a0mm and 0.20\u2009\u00b1\u20090.15\u00a0mm (p\u2009=\u20090.01) in the combination and control groups, respectively. The change in axial length in the two groups showed significant differences only in the first four months (median [Q1, Q3] (95% CI), -0.01\u00a0mm [-0.07, 0.05] (-0.06, 0.04) vs. 0.04\u00a0mm [0.00, 0.10] (0.02, 0.09); p\u2009=\u20090.04), but no difference thereafter. Multivariate linear regression analysis showed that the axial elongation was significantly slower in the combination group than in the control group (standard \u03b2 = -0.10, p\u2009=\u20090.02). PD significantly increased by 0.45\u00a0mm [0.20, 0.68] at the 4th month visit (p\u2009&lt;\u20090.001) and then remained stable in the combination group. The PD in the control group and AMP in the two groups remained stable from baseline to 12 months (all p\u2009&gt;\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The combination therapy was more effective than the OK lens alone in slowing axial elongation after 12 months of treatment, and mainly in the first 4 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>\n                      The First Affiliated Hospital of Zhengzhou University, ChiCTR2000033904. Registered 16\/06\/2020,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/login.aspx?referurl=%2flistbycreater.aspx\">http:\/\/www.chictr.org.cn\/login.aspx?referurl=%2flistbycreater.aspx<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-022-02635-0","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T10:09:54Z","timestamp":1668506994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Shiao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuena","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhong","family":"li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aicun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"issue":"5","key":"2635_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.5.2","volume":"62","author":"P Sankaridurg","year":"2021","unstructured":"Sankaridurg P, Tahhan N, Kandel H. IMI impact of myopia. Investig Ophthalmol Vis Sci. 2021;62(5):2\u20132.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"2635_CR2","doi-asserted-by":"publisher","first-page":"e0130646","DOI":"10.1371\/journal.pone.0130646","volume":"10","author":"Y Sun","year":"2015","unstructured":"Sun Y, Xu F, Zhang T, Liu M, Wang D, Chen Y, Liu Q. Correction: orthokeratology to control myopia progression: a meta-analysis. PLoS ONE. 2015;10(6):e0130646.","journal-title":"PLoS ONE"},{"issue":"4","key":"2635_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/ICL.0000000000000520","volume":"44","author":"MJ Lipson","year":"2018","unstructured":"Lipson MJ, Brooks MM, Koffler BH. The role of orthokeratology in myopia control: a review. Eye Contact Lens. 2018;44(4):224\u201330.","journal-title":"Eye Contact Lens"},{"issue":"7","key":"2635_CR4","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1167\/iovs.11-8453","volume":"53","author":"T Hiraoka","year":"2012","unstructured":"Hiraoka T, Kakita T, Okamoto F, Takahashi H, Oshika T. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53(7):3913\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2635_CR5","doi-asserted-by":"publisher","first-page":"22267","DOI":"10.1038\/s41598-021-01708-2","volume":"11","author":"C Cui","year":"2021","unstructured":"Cui C, Li X, Lyu Y, Wei L, Zhao B, Yu S, Rong J, Bai Y, Fu A. Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial. Sci Rep. 2021;11(1):22267.","journal-title":"Sci Rep"},{"issue":"2","key":"2635_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391\u20139.","journal-title":"Ophthalmology"},{"issue":"7","key":"2635_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X, Tang SM, Yip BHK, Kam KW, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP. Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) Study: phase 2 report. Ophthalmology. 2020;127(7):910\u20139.","journal-title":"Ophthalmology"},{"issue":"4","key":"2635_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/OPX.0b013e31820f16fb","volume":"88","author":"P Kang","year":"2011","unstructured":"Kang P, Swarbrick H. Peripheral refraction in myopic children wearing orthokeratology and gas-permeable lenses. Optom Vis Sci. 2011;88(4):476\u201382.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"2635_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ophtha.2014.07.042","volume":"122","author":"T Hiraoka","year":"2015","unstructured":"Hiraoka T, Kakita T, Okamoto F, Oshika T. Influence of ocular wavefront aberrations on axial length elongation in myopic children treated with overnight orthokeratology. Ophthalmology. 2015;122(1):93\u2013100.","journal-title":"Ophthalmology"},{"issue":"5","key":"2635_CR10","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1097\/OPX.0b013e31819fa5aa","volume":"86","author":"A Mathur","year":"2009","unstructured":"Mathur A, Atchison DA. Effect of orthokeratology on peripheral aberrations of the eye. Optom Vis Sci. 2009;86(5):E476\u201384.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"2635_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/opo.12052","volume":"33","author":"NA McBrien","year":"2013","unstructured":"McBrien NA, Stell WK, Carr B. How does atropine exert its anti-myopia effects? Ophthalmic Physiol Opt. 2013;33(3):373\u20138.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"9","key":"2635_CR12","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1167\/iovs.12-9943","volume":"53","author":"B Arumugam","year":"2012","unstructured":"Arumugam B, McBrien NA. Muscarinic antagonist control of myopia: evidence for m4 and m1 receptor-based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew. Invest Ophthalmol Vis Sci. 2012;53(9):5827\u201337.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2635_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","volume":"157","author":"A Chia","year":"2014","unstructured":"Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157(2):451\u20137.e1.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2635_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1097\/OPX.0000000000000034","volume":"90","author":"J Santodomingo-Rubido","year":"2013","unstructured":"Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Guti\u00e9rrez-Ortega R. Factors preventing myopia progression with orthokeratology correction. Optom Vis Sci. 2013;90(11):1225\u201336.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"2635_CR15","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.1038\/s41598-021-88719-1","volume":"11","author":"A Fu","year":"2021","unstructured":"Fu A, Stapleton F, Wei L, Wang W, Zhao B, Watt K. Risk factors for rapid axial length elongation with low concentration atropine for myopia control. Sci Rep. 2021;11(1):11729.","journal-title":"Sci Rep"},{"issue":"5","key":"2635_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10384-018-0608-3","volume":"62","author":"N Kinoshita","year":"2018","unstructured":"Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kakehashi A. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Jpn J Ophthalmol. 2018;62(5):544\u201353.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"2635_CR17","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1038\/s41598-020-69710-8","volume":"10","author":"N Kinoshita","year":"2020","unstructured":"Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kaburaki T, Kakehashi A. Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Sci Rep. 2020;10(1):12750.","journal-title":"Sci Rep"},{"issue":"5","key":"2635_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","volume":"40","author":"Q Tan","year":"2020","unstructured":"Tan Q, Ng AL, Choy BN, Cheng GP, Woo VC, Cho P. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial. Ophthalmic Physiol Opt. 2020;40(5):557\u201366.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"9","key":"2635_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/jcm7090259","volume":"7","author":"L Wan","year":"2018","unstructured":"Wan L, Wei CC, Chen CS, Chang CY, Lin CJ, Chen JJ, Tien PT, Lin HJ. The synergistic effects of orthokeratology and atropine in slowing the progression of myopia. J Clin Med. 2018;7(9):259.","journal-title":"J Clin Med"},{"key":"2635_CR20","doi-asserted-by":"crossref","unstructured":"Yang N, Bai J, Liu L. Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis. Eur J Ophthalmol 2021, 1120672121998903.","DOI":"10.1177\/1120672121998903"},{"issue":"5","key":"2635_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1159\/000510779","volume":"64","author":"S Wang","year":"2021","unstructured":"Wang S, Wang J, Wang N. Combined orthokeratology with atropine for children with myopia: a meta-analysis. Ophthalmic Res. 2021;64(5):723\u201331.","journal-title":"Ophthalmic Res"},{"issue":"8","key":"2635_CR22","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3390\/jcm9082371","volume":"9","author":"JM S\u00e1nchez-Gonz\u00e1lez","year":"2020","unstructured":"S\u00e1nchez-Gonz\u00e1lez JM, De-Hita-Cantalejo C, Baustita-Llamas MJ, S\u00e1nchez-Gonz\u00e1lez MC, Capote-Puente R. The combined effect of low-dose atropine with orthokeratology in pediatric myopia control: review of the current treatment status for myopia. J Clin Med. 2020;9(8):2371.","journal-title":"J Clin Med"},{"issue":"11","key":"2635_CR23","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1111\/j.1538-7836.2011.04507.x","volume":"9","author":"J Beyer-Westendorf","year":"2011","unstructured":"Beyer-Westendorf J, B\u00fcller H. External and internal validity of open label or double\u2010blind trials in oral anticoagulation: better, worse or just different? J Thromb Haemost. 2011;9(11):2153\u20138.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2635_CR24","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1167\/iovs.02-0680","volume":"44","author":"A Alharbi","year":"2003","unstructured":"Alharbi A, Swarbrick HA. The effects of overnight orthokeratology lens wear on corneal thickness. Invest Ophthalmol Vis Sci. 2003;44(6):2518\u201323.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"2635_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.ICL.0000140637.58027.9B","volume":"30","author":"PS Soni","year":"2004","unstructured":"Soni PS, Nguyen TT, Bonanno JA. Overnight orthokeratology: refractive and corneal recovery after discontinuation of reverse-geometry lenses. Eye Contact Lens. 2004;30(4):254\u201364.","journal-title":"Eye Contact Lens"},{"issue":"4","key":"2635_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/jop.1998.14.331","volume":"14","author":"LL Lin","year":"1998","unstructured":"Lin LL, Shih YF, Hsiao CH, Su TC, Chen CJ, Hung PT. The cycloplegic effects of cyclopentolate and tropicamide on myopic children. J Ocul Pharmacol Ther. 1998;14(4):331\u20135.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"2635_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.optom.2017.09.001","volume":"11","author":"N Yazdani","year":"2018","unstructured":"Yazdani N, Sadeghi R, Momeni-Moghaddam H, Zarifmahmoudi L, Ehsaei A. Comparison of cyclopentolate versus tropicamide cycloplegia: a systematic review and meta-analysis. J Optom. 2018;11(3):135\u201343.","journal-title":"J Optom"},{"issue":"4","key":"2635_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40123-019-00217-w","volume":"8","author":"GL Larkin","year":"2019","unstructured":"Larkin GL, Tahir A, Epley KD, Beauchamp CL, Tong JT, Clark RA. Atropine 0.01% eye drops for myopia control in American children: a multiethnic sample across three US sites. Ophthalmol Ther. 2019;8(4):589\u201398.","journal-title":"Ophthalmol Ther"},{"issue":"18\u201319","key":"2635_CR29","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/S0024-3205(03)00064-X","volume":"72","author":"G Duncan","year":"2003","unstructured":"Duncan G, Collison DJ. Role of the non-neuronal cholinergic system in the eye: a review. Life Sci. 2003;72(18\u201319):2013\u20139.","journal-title":"Life Sci"},{"issue":"3","key":"2635_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.mehy.2007.07.023","volume":"70","author":"SB Prepas","year":"2008","unstructured":"Prepas SB. Light, literacy and the absence of ultraviolet radiation in the development of myopia. Med Hypotheses. 2008;70(3):635\u20137.","journal-title":"Med Hypotheses"},{"issue":"19","key":"2635_CR31","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.visres.2009.07.011","volume":"49","author":"EL Smith","year":"2009","unstructured":"Smith EL, Hung LF, Huang J. Relative peripheral hyperopic defocus alters central refractive development in infant monkeys. Vis Res. 2009;49(19):2386\u201392.","journal-title":"Vis Res"},{"issue":"11","key":"2635_CR32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/00006324-199811000-00019","volume":"75","author":"HA Swarbrick","year":"1998","unstructured":"Swarbrick HA, Wong G, O\u2019Leary DJ. Corneal response to orthokeratology. Optom Vis Sci. 1998;75(11):791\u20139.","journal-title":"Optom Vis Sci"},{"issue":"7","key":"2635_CR33","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00417-021-05106-2","volume":"259","author":"Y Song","year":"2021","unstructured":"Song Y, Zhu S, Yang B, Wang X, Ma W, Dong G, Liu L. Accommodation and binocular vision changes after wearing orthokeratology lens in 8- to 14-year-old myopic children. Graefes Arch Clin Exp Ophthalmol. 2021;259(7):2035\u201345.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"2635_CR34","first-page":"1234","volume":"11","author":"Y Yang","year":"2018","unstructured":"Yang Y, Wang L, Li P, Li J. Accommodation function comparison following use of contact lens for orthokeratology and spectacle use in myopic children: a prospective controlled trial. Int J Ophthalmol. 2018;11(7):1234\u20138.","journal-title":"Int J Ophthalmol"},{"issue":"12","key":"2635_CR35","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/OPX.0000000000000037","volume":"90","author":"J Cooper","year":"2013","unstructured":"Cooper J, Eisenberg N, Schulman E, Wang FM. Maximum atropine dose without clinical signs or symptoms. Optom Vis Sci. 2013;90(12):1467\u201372.","journal-title":"Optom Vis Sci"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02635-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02635-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02635-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T10:12:48Z","timestamp":1668507168000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02635-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2635"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02635-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Board of the First Affiliated Hospital of Zhengzhou University. Informed consent was obtained from parent and\/or legal guardians of all participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}